Difficulty: Medium
Average Score: 77%
Practice
A 42-year-old man with ALS presents to his primary care physician for follow-up. He has not had any issues in the last few years and does not need supplemental oxygen. Which of the following agents may be beneficial to delay the need for ventilator support in this patient?
Correct answer
C
Rationale
The correct answer is C) Riluzole. Riluzole is a medication approved for the treatment of amyotrophic lateral sclerosis (ALS) that has been shown to delay the need for ventilator support in some patients. It is believed to work by reducing the release of glutamate, which can be toxic to nerve cells.
Option A) Memantine is used to treat Alzheimer's disease and does not have a known benefit in delaying the need for ventilator support in ALS patients.
Option B) Metronidazole is an antibiotic and has no role in the management of ALS.
Option D) Prednisolone is a corticosteroid that is not recommended for the treatment of ALS and would not delay the need for ventilator support.
Educationally, understanding the pharmacological management of ALS is crucial for healthcare providers to provide optimal care to patients with this condition. Knowing the specific medications that can help delay disease progression and improve quality of life is essential in managing ALS effectively. Riluzole, in particular, has been shown to be beneficial in this regard and should be considered in the treatment plan for patients with ALS to potentially delay the need for ventilator support.
Option A) Memantine is used to treat Alzheimer's disease and does not have a known benefit in delaying the need for ventilator support in ALS patients.
Option B) Metronidazole is an antibiotic and has no role in the management of ALS.
Option D) Prednisolone is a corticosteroid that is not recommended for the treatment of ALS and would not delay the need for ventilator support.
Educationally, understanding the pharmacological management of ALS is crucial for healthcare providers to provide optimal care to patients with this condition. Knowing the specific medications that can help delay disease progression and improve quality of life is essential in managing ALS effectively. Riluzole, in particular, has been shown to be beneficial in this regard and should be considered in the treatment plan for patients with ALS to potentially delay the need for ventilator support.